Simultaneous determination of everolimus and cyclosporine concentrations by HPLC with ultraviolet detection.
In the clinical practice of organ transplantation everolimus (RAD) is used in combination with cyclosporine (CsA), the most common antirejection agent. Both drugs show a narrow therapeutic window, which requires strict monitoring of their blood concentration. Simple methods for simultaneous measurement of RAD and CsA concentration are needed. As we have recently developed an HPLC-UV assay for RAD determination, we decided to implement it to allow concomitant measurement of CsA. The within- and between-day coefficients of variation of the measurement were less than 12.1% for RAD and 9.8% for CsA. The within- and between-day inaccuracy of quality control samples were less than 9.7% for RAD and less than 4.9% for CsA. The method was found accurate and precise and useful for simultaneous therapeutic monitoring of the two drugs.
Baldelli
Sara
S
Department of Medicine and Transplantation, Ospedali Riuniti di Bergamo -, Mario Negri Institute for Pharmacological Research Via Gavazzeni, 11 - 24125, Bergamo, Italy.
Zenoni
Stefania
S
Merlini
Simona
S
Perico
Norberto
N
Cattaneo
Dario
D
D002138:Calibration; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D016572:Cyclosporine / Q000097:blood*; D000068338:Everolimus; D006801:Humans; D015203:Reproducibility of Results; D020123:Sirolimus / Q000031:analogs & derivatives* / Q000097:blood; D013056:Spectrophotometry, Ultraviolet / Q000379:methods*
D016572:Cyclosporine; D000068338:Everolimus; D020123:Sirolimus